Pharmacology of Valbenazine and Deutetrabenazine: A Narrative Review

被引：0
|
作者：
Cutler, Andrew J. [1 ]
Chepke, Craig [2 ]
Shah, Chirag [3 ]
Lundt, Leslie [3 ]
机构：
[1] SUNY Upstate Med Univ, Lakewood Ranch, FL USA
[2] Univ N Carolina, Sch Med, Charlotte, NC USA
[3] Neurocrine Biosci, San Diego, CA USA
来源：
ANNALS OF CLINICAL PSYCHIATRY | 2021年 / 33卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
13
引用
收藏
页码：17 / 18
页数：2
相关论文
共 50 条
  • [1] Pharmacology of Valbenazine and Deutetrabenazine: A Narrative Review
    Cutler, Andrew J.
    Chepke, Craig
    Shah, Chirag
    Lundt, Leslie
    [J]. ANNALS OF CLINICAL PSYCHIATRY, 2022, 34 (01) : 5 - 7
  • [2] A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine
    Patel, Rikinkumar S.
    Mansuri, Zeeshan
    Motiwala, Fatima
    Saeed, Hina
    Jannareddy, Namrata
    Patel, Hiren
    Zafar, Muhammad Khalid
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2019, 9
  • [3] Pharmacokinetic and Pharmacologic Characterization of the Dihydrotetrabenazine Isomers of Deutetrabenazine and Valbenazine
    Brar, Satjit
    Vijan, Arjun
    Scott, Fiona L.
    Jimenez, Roland
    Zhang, Hui
    Grigoriadis, Dimitri E.
    Loewen, Gordon
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (04): : 447 - 456
  • [4] Comparative Analysis of Deutetrabenazine and Valbenazine as VMAT2 Inhibitors for Tardive Dyskinesia: A Systematic Review
    Golsorkhi, Mohadese
    Koch, Jessa
    Pedouim, Farzin
    Frei, Karen
    Bondariyan, Niloofar
    Dashtipour, Khashayar
    [J]. TREMOR AND OTHER HYPERKINETIC MOVEMENTS, 2024, 14 : 1 - 12
  • [5] Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia
    Ganz, Michael L.
    Chavan, Ameya
    Dhanda, Rahul
    Serbin, Michael
    Yonan, Charles
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 103 - 113
  • [6] Indirect treatment comparison of valbenazine and deutetrabenazine efficacy and safety in tardive dyskinesia
    Aggarwal, Saurabh
    Serbin, Michael
    Yonan, Chuck
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (13) : 1077 - 1088
  • [7] Valbenazine and deutetrabenazine: Vesicular monoamine transporter 2 inhibitors for tardive dyskinesia
    Khorassani, Farah
    Luther, Kiranjit
    Talreja, Om
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (03) : 167 - 174
  • [8] LONG-TERM COST-EFFECTIVENESS OF VALBENAZINE AND DEUTETRABENAZINE FOR TARDIVE DYSKINESIA
    Harrigan, K.
    Walton, S. M.
    Huang, S. P.
    Kumar, V. M.
    Chapman, R. H.
    Atlas, S. J.
    Agboola, F. O.
    Ollendorf, D. A.
    Touchette, D. R.
    [J]. VALUE IN HEALTH, 2018, 21 : S184 - S184
  • [9] COST-EFFECTIVENESS ANALYSIS OF VALBENAZINE COMPARED WITH DEUTETRABENAZINE FOR THE MANAGEMENT OF HUNTINGTON CHOREA
    Kim, H.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S65 - S65
  • [10] Valbenazine and Deutetrabenazine as possible treatments for neuroleptic-induced supersensitivity psychosis and antipsychotic dependence
    Skaff, Richard
    [J]. CNS SPECTRUMS, 2019, 24 (04) : 352 - 353
12345